CTI BioPharma Corp. (CTIC) Fundamentals

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. Its therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.
SHARE INFORMATION
Market Cap$ 643,989,278
Shares Outstanding114,385,307
Float105,228,388
Percent Float91.99%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -1.09
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions233
Institutional Holdings Date2022-08-31
Institutional Bought Previous 3 Months23,916,311
Institutional Holdings Percent101.3%
Institutional Sold Previous 3 Months5,531,491
Insider Holdings Date2022-08-31
Insider Bought Previous 3 Months8,700,460
Insider Holdings Percent6.5
Insider Sold Previous 3 Months9,216,811
Insider Shares Owned7,445,816
TRADING INFO
52 Week High$ 7.80
52 Week Low$ 1.43
52 Week High Change$ 92.81
21 Day Moving Average$ 6.0348
21 Day Extended Moving Average$ 5.934
50 Day Moving Average$ 6.1742
50 Day Extended Moving Average$ 6.0184
200 Day Moving Average$ 4.6279
200 Day Extended Moving Average$ 4.9835
10 Day Average Volume4,423,710
20 Day Average Volume3,829,725
30 Day Average Volume3,908,892
50 Day Average Volume4,385,887
Alpha0.040339
Beta0.8765
Standard Deviation0.307761
R20.020651
7 Day Price Change$ -0.16
7 Day Percent Change-2.76%
21 Day Price Change$ -0.75
21 Day Percent Change-11.76%
30 Day Price Change$ -0.38
30 Day Percent Change-6.32%
Month to Date Price Change$ -0.65
Month to Date Percent Change-10.35%
Quarter to Date Price Change$ -0.34
Quarter to Date Percent Change-5.7%
180 Day Price Change$ 0.59
180 Day Percent Change11.71%
200 Day Price Change$ 1.04
200 Day Percent Change22.66%
Year to Date Price Change$ 3.15
Year to Date Percent Change127.02%

CTI BioPharma Corp. (CTIC) Key Ratios

PROFITABILITY
EBIT Margin-770.4%
EBITDA Margin-762.5%
Pre-Tax Profit Margin-551.9%
Profit Margin Count0.0%
Gross Margin91.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 14,624,000
Revenue Per Share$ 0.1278
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-22.90
Total Debt To Equity13.40
Int Coverage-13.90
Current Ratio3.60
Leverage Ratio59.70
Quick Ratio3.50
Long Term Debt To Capital0.35
VALUATION MEASURES
PE Ratio-4.80
Enterprise Value$ 630,594,017
Price to Sales44.0365
Price to Free Cash-6.70
PE High Last 5 Years-3.50
Price To Book112.60
Price To Cash Flow0.00
PE Low Last 5 Years-1.90
Price to Tangible Book-22.90
MANAGEMENT EFFECTIVENESS
Receivables Turnover3.60
Invoice Turnover3.40
Assets Turnover0.20
Return Assets-119.00
Return on Equity-490.50
Return on Capital-145.66

CTI BioPharma Corp. (CTIC) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOAdam R. Craig
Emplyoees124
Last AuditUE
CIK0000891293
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address3101 Western Avenue
Suite 800
Seattle, WA 98121
Websitehttps://www.ctibiopharma.com
Facsimile+1 206 284-6206
Telephone+1 206 282-7100
Emailinvest@ctibiopharma.com


Your Recent History
NASDAQ
CTIC
CTI BioPha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.